Complexities in assessing the effectiveness of inactivated influenza vaccines

Eurosurveillance

Volumn 18, Issue 7, 2013, Pages

  Kelly, H ^a,b   Steffens, I ^c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b The Australian National University   (Australia)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

DRUG EFFICACY; EDITORIAL; HUMAN; INFLUENZA; INFLUENZA B; INFLUENZA VIRUS; POLYMERASE CHAIN REACTION;

EID: 84874186922     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Vaccines against influenza WHO position paper-November 2012. Week Epidemiol Record 2012; 87:461-76.
2. Osterholm MT, Kelley NS, Manske JM, Ballering KS, Leighton TR, Moore KA. The compelling need for game-changing influenza vaccines. University of Minnesota Center for Infectious Disease Research and Policy, Oct 2012. Available from: www.cidrap.umn.edu/cidrap/center/mission/articles/ ccivi-landing.html
3. Nicoll A, Sprenger M. Low effectiveness undermines promotion of seasonal influenza vaccine. Lancet Inf Dis 2013; 13:7-9. http://dx.doi.org/10.1016/S1473-3099(12)70313-4
4. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012 Jan;12(1):36-44. http:// dx.doi.org/10.1016/S1473-3099(11)70295-X
5. Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A, Primary Health Care Sentinel Network, Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill. 2013;18(5):pii=20388. Available from: http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20388 PMid:23399423
6. Pebody RG, Andrews N, McMenamin J, Durnall H, Ellis J, Thompson CI, Robertson C, Cottrell S, Smyth B, Zambon M, Moore C, Fleming DM, Watson JM. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill. 2013;18(5):pii=20389. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20389
7. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jiménez-Jorge S, Horváth JK, Daviaud I, Guiomar R, Necula G, Bella A, O'Donnell J, Głuchowska M, Ciancio BC, Nicoll A, Moren A. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013;18(5):pii=20390. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20390 PMid:23399425
8. Skowronski DM, Janjua NZ, De Serres G, Dickinson JA, Winter A, Mahmud SM, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill. 2013;18(5):pii=20394 Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20394 PMid:23399422
9. McMenamin J, Andrews N, Robertson C, Fleming DM, Durnall H, von Wissmann B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill. 2013;18(5):pii=20393. Available from:http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20393
10. Bragstad K, Emborg HD, Kølsen Fischer T, Voldstedlund M, Gubbels S, et al. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13-a rapid epidemiological and virological assessment. Euro Surveill. 2013;18(6):pii=20397. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20397
11. Valenciano M, Ciancio BC, on behalf of the I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):pii=20281. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20281
12. Fielding JE, Grant KA, Tran T, Kelly HA. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveill. 2012;17(11):pii=20115. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20115 PMid:22449867
13. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012; 55:332-42. http:// dx.doi.org/10.1093/cid/cis431 PMid:22539661
14. Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Pérez-Vilar S, Micó-Esparza JL et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study. Vaccine 2012; 30:5174-20. http://dx.doi. org/10.1016/j.vaccine.2012.07.006 PMid:22819720
15. Van der Hoek W, Dijkstra F, de Lange MM, Donker GA, Meijer A, van der Sande MA. Letter to the editor: Influenza vaccine effectiveness: heterogeneity in estimates for the 2012/13 season. Euro Surveill. 2013;18(7):pii=20399. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20399
16. Mølbak K, Emborg HD, Gubbels S, Bragstad K, Krause TG, Kølsen Fischer T. Authors' reply: Influenza vaccine effectiveness: heterogeneity in estimates for the 2012/13 season. Euro Surveill. 2013;18(7):pii=20401. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20401
17. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Geneva: WHO; 2012. Available from: http://www.who.int/influenza/vaccines/virus/ recommendations/201202_recommendation.pdf
18. Valenciano M, Kissling E, I-MOVE case-control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill. 2013;18(7):pii=20400. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20400
19. Centers for Disease Control and Prevention (CDC). Early estimates of seasonal influenza vaccine effectiveness-United States, January 2013. MMWR Morb Mortal Wkly Rep. 2013;62:32-5. PMid:23325354
20. Kelly H, Sullivan S, Grant K, Fielding J. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-11. Influenza Other Respi Viruses. 2012 Oct 19.
21. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):140016. http://dx.doi.org/10.1073/ pnas.96.24.14001 PMid:10570188 PMCid:24180
22. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007 Sep 28;25(39-40):6852-62. http://dx.doi.org/10.1016/j.vaccine.2007.07.027 PMid:17719149
23. Keitel WA, Catet TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol. 1988 Feb;127(2):353-64. PMid:3337087
24. Centers for Disease Control and Prevention (CDC). Update: Flu Season and Vaccine Effectiveness. Atlanta: CDC; 2013. Available from: http://www.cdc.gov/media/releases/2013/ t0111_flu_season.html. Accessed 5 February 2013.
25. Castilla J, Martínez-Baz I, Martínez-Artola V, Fernandez-Alonso M, Reina G, Guevara M, García Cenoz M, Elía F, Alvarez N. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill. 2013;18(7):pii=20404. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20404